CIK 0001582313 · Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980661854
- Phone
- (604) 484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Kelly Thomas Patrick Chief Financial Officer | Option exercise | +7,500 | 22,500 | ||
| 2026-10-15 | Kelly Thomas Patrick Chief Financial Officer | Option exercise · Restricted Share Units | −7,500 | 22,500 | ||
| 2026-09-30 | Kelly Thomas Patrick Chief Financial Officer | Purchase | +15,000 | $37.32 | $560K | 15,000 |
| 2026-09-30 | MORTIMER IAN PRESIDENT & CEO | Purchase | +30,000 | $37.38 | $1.1M | 49,923 |
| 2026-09-01 | Svoronos Dawn Director | Option exercise | +5,144 | $8.15 | $42K | 31,373 |
| 2026-09-01 | Svoronos Dawn Director | Option exercise · Stock Option (Right to Buy) | −5,144 | 0 | ||
| 2026-08-28 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale 10b5-1 | −6,368 | $60.17 | $383K | 702 |
| 2026-08-28 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale 10b5-1 | −700 | $60.98 | $43K | 2 |
| 2026-08-11 | GANNON STEVEN Director | Sale | −10,000 | $64.06 | $641K | 1,870 |
| 2026-06-05 | PATOU GARY Director | Sale 10b5-1 | −1,322 | $53.14 | $70K | 24,896 |
| 2026-06-05 | Cannon Gillian Director | Sale 10b5-1 | −1,190 | $53.14 | $63K | 1,455 |
| 2026-06-03 | PATOU GARY Director | Grant or award · Share Option (Right to Buy) | +10,507 | 10,507 | ||
| 2026-06-03 | PATOU GARY Director | Grant or award · Restricted Share Units | +1,593 | 1,593 | ||
| 2026-06-03 | Machado Patrick Director | Grant or award · Share Option (Right to Buy) | +10,507 | 10,507 | ||
| 2026-06-03 | Machado Patrick Director | Grant or award · Restricted Share Units | +1,593 | 1,593 | ||
| 2026-06-03 | Gover Justin D. Director | Grant or award · Share Option (Right to Buy) | +10,507 | 10,507 | ||
| 2026-06-03 | Gover Justin D. Director | Grant or award · Restricted Share Units | +1,593 | 1,593 | ||
| 2026-06-03 | GAROFALO ELIZABETH A. Director | Grant or award · Share Option (Right to Buy) | +10,507 | 10,507 | ||
| 2026-06-03 | GAROFALO ELIZABETH A. Director | Grant or award · Restricted Share Units | +1,593 | 1,593 | ||
| 2026-06-03 | GANNON STEVEN Director | Grant or award · Share Option (Right to Buy) | +10,507 | 10,507 |
Page 1 of 16 · 308 trades